New drug trial aims to protect hearts during attack treatment
Disease control
Not yet recruiting
This study tests whether a single dose of Xolatryp given during emergency heart attack treatment can improve recovery. 300 adults having a severe heart attack will receive either Xolatryp or a placebo infusion during their procedure. Researchers will monitor heart health for 30 d…
Phase: PHASE2 • Sponsor: Nyrada Pty Ltd • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC